TIS tissue therapies limited

stem cell retraction, page-6

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    There is a conflict though....

    QUT spun TIS out to commercialise VG and related technologies and has been using the company's resources to help fund its research even when there is a dangerous lack of company funds and no cashflow.

    It was instructive to see soem of the QUT blurbs about VG associated with the Boston junket last year. No mention of TIS...not even "we would like to thank mug TIS shareholders for helping us fund our research...oh yeah and thanks for shouting our junket too!"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.